atomoxetine hydrochloride has been researched along with olanzapine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bercu, JP; Fiori, JM; Meyerhoff, RD; Parke, NJ | 1 |
| Ball, MP; Buchanan, RW; Feldman, S; Kelly, DL; McMahon, RP; Warren, KR | 1 |
| Gangadhar, BN; Rao, MG; Raveendranathan, D; Varambally, S; Venkatasubramanian, G | 1 |
| Holzer, B; Lehman, R; Lopes, V | 1 |
| Aronen, ET; Rättö, H; Saastamoinen, LK; Varimo, E | 1 |
2 trial(s) available for atomoxetine hydrochloride and olanzapine
| Article | Year |
|---|---|
Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Appetite Depressants; Atomoxetine Hydrochloride; Attention; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Clozapine; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Exercise; Female; Humans; Life Style; Male; Maryland; Middle Aged; Neuropsychological Tests; Obesity; Olanzapine; Propylamines; Psychotic Disorders; Schizophrenia | 2011 |
Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Propylamines; Time Factors; Treatment Outcome; Weight Gain | 2013 |
6 other study(ies) available for atomoxetine hydrochloride and olanzapine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human health risk assessments for three neuropharmaceutical compounds in surface waters.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Benzodiazepines; Drug Residues; Duloxetine Hydrochloride; Environmental Exposure; Fishes; Food Analysis; Forecasting; Humans; Models, Statistical; No-Observed-Adverse-Effect Level; Olanzapine; Propylamines; Risk Assessment; Thiophenes; United States; Water Pollutants, Chemical; Water Supply | 2008 |
Academy of Medicine Singapore-Ministry of Health clinical practice guidelines: Autism Spectrum Disorders in pre-school children.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Benzodiazepines; Central Nervous System Stimulants; Child Development Disorders, Pervasive; Child, Preschool; Dopamine Antagonists; Humans; Mass Screening; Methylphenidate; Olanzapine; Prognosis; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Singapore | 2010 |
Atomoxetine-induced vocal tics in a patient with schizophrenia.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Humans; Male; Olanzapine; Propylamines; Schizophrenia; Tics | 2012 |
Polypharmacy in children and adolescents initiating antipsychotic drug in 2008-2016: a nationwide register study.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Child; Female; Humans; Male; Olanzapine; Polypharmacy; Psychotropic Drugs | 2023 |